Cytocidal effect of alpha-methylornithine, a competitive inhibitor of ornithine decarboxylase, on ehrlich ascites tumor cells in vivo.
The antiproliferative effect of alpha-methylornithine, an inhibitor of the initial and rate-limiting step in polyamine biosynthesis, was studied on Ehrlich ascites tumor cells grown in vivo. To assess drug-induced cell lethality, the loss of 125I from mice harboring 5-[125I] iodo-2'-deoxyuridine-labeled mouse tumor cells was determined during the course of alpha-methylornithine treatment. Mice that received the drug showed a significant increase in their rate of 125I excretion as compared to controls. This suggests that alpha-methylornithine kills an additional fraction of tumor cells beyond the fraction normally dying.